BioSpace News Archive

Nacuity Pharmaceuticals, Inc. today announced that the first patients have been implanted in the final cohort of the Phase 1/2 clinical trial evaluating NPI-002 for delayed cataract progression in patients undergoing vitrectomy.

Denovo Biopharma LLC (Denovo) today announced that the California Institute for Regenerative Medicine (CIRM) has awarded a $11.8M grant for further development of DB107, Denovo’s DGM7™ biomarker–guided late–stage gene therapy, for high–grade glioma (HGG) including glioblastoma (GBM), a malignant brain cancer.

Mesogen Inc. out of The Woodlands, Texas, has developed a transplantable Retinal Pigmented Epithelium patch to cure Macular Degeneration Blindness using autologous bone marrow-derived stem cells that carry no teratoma tumor risk and requires no immunosuppression.

Akili, Inc. including an amendment to its strategic distribution agreement with Shionogi & Co., Ltd. (“Shionogi”), a leading global pharmaceutical company.

Lineage Cell Therapeutics, Inc. today announced that the Company has received an Education Conference II Grant from the California Institute for Regenerative Medicine (CIRM).

Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX) is pleased to announce that’s its licensor Emtora Biosciences has announced that results of a Phase 2 clinical trial of eRapa in Familial Adenomatous Polyposis (“FAP”) are to be presented at the prestigious 2024 Digestive Disease Week annual meeting in Washington DC on May 18-21, 2024.

Wrocław, Poland-based Biotts, a biopharmaceutical company and global pioneer in Transdermal Drug Delivery (through the skin in the form of patches without injections),

Creatv Bio, A Division of Creatv MicroTech, Inc. (Creatv), (https://creatvbio.com/) and collaborators were invited to present clinical data from Creatv’s blood test for cancer screening and diagnostics at the 1st International Conference on Polyploid Giant Cancer Cells: Biology and Clinical Applications – held February 16 and 17 at The University of Texas MD Anderson Cancer Center in Houston, Texas.

Intego Clinical, a biometrics Clinical Research Organization (CRO) that helps leading life science companies